Home Newsfeeds ‘Beijing backpedaling on planned Biden-Xi meeting at G20’ -Politico

‘Beijing backpedaling on planned Biden-Xi meeting at G20’ -Politico

https://www.politico.com/news/2022/10/14/biden-xi-meeting-g20-00061919

byMichael Horton

October 14, 2022

1 minute read

https://www.politico.com/news/2022/10/14/biden-xi-meeting-g20-00061919

US Lime & Minerals Q2 EPS $1.80 Down From $1.96 YoY, Sales $60.49M Up From $49.16M YoY

By Michael Horton

July 27, 5:38 PM

US Lime & Minerals (NASDAQ:USLM) reported quarterly earnings of $1.80 per share. This is a 8.16 percent decrease over earnings of $1.96 per share from the same period last year. The company reported $60.49 million in

USLM

Premier, Inc.’s PINC AI Applied Sciences And Datavant Collaborate To Enable Next-Generation Clinical Trials

By Benzinga Newsdesk

February 13, 9:36 AM

Builds on existing partnership by further leveraging the combined power of real-world data, real-world evidence and privacy-preserving record linkage technology to help solve key clinical trial challenges.Aims to

PINC

AstraZeneca Shares Data At EASL And ESMO World GI For IMFINZI Combinations In Patients With Liver And Biliary Tract Cancers

By Bill Haddad

July 1, 9:02 AM

survival vs. sorafenib in patients with unresectable liver cancer regardless of baseline liver functional reserve TOPAZ-1 Phase III trial subgroup analysis showed the addition of IMFINZI to standard-of-care chemotherapy

AZN

OSI Systems Shares Slide Post Q4 Results, Provides FY23 Guidance

By Akanksha Bakshi

August 18, 5:33 PM

OSI Systems, Inc. (NASDAQ:OSIS) reported fourth-quarter revenue growth of 1.4% year-over-year to $336.82 million, beating the consensus of $336.38 million.…

OSIS

‘Beijing backpedaling on planned Biden-Xi meeting at G20’ -Politico

Related Posts

US Lime & Minerals Q2 EPS $1.80 Down From $1.96 YoY, Sales $60.49M Up From $49.16M YoY

Premier, Inc.’s PINC AI Applied Sciences And Datavant Collaborate To Enable Next-Generation Clinical Trials

AstraZeneca Shares Data At EASL And ESMO World GI For IMFINZI Combinations In Patients With Liver And Biliary Tract Cancers

OSI Systems Shares Slide Post Q4 Results, Provides FY23 Guidance